Sunday - March 29, 2026

Category Archives: Marketing & Sales

Fuchs Dystrophy Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Kowa Pharma, Trefoil Therapeutics, Design Therapeutics, Emmecell, Santen

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Fuchs Dystrophy pipeline constitutes 5+ key companies continuously working towards developing 5+ Fuchs Dystrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Projecting the Global Cardiac Ablation Devices Market Size to Expand at a 13.25% CAGR Through 2032, DelveInsight Analysis

Cardiac Ablation Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.   As per DelveInsight’s assessment, The cardiac ablation devices market is experiencing … Continue reading →

Sarcopenia Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Oncocross, Biophytis, MyMD Pharma, Novartis, Regeneron Pharma, Merck Sharp & Dohme

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Sarcopenia pipeline constitutes 18+ key companies continuously working towards developing 20+ Sarcopenia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   … Continue reading →

Fibrodysplasia Ossificans Progressiva Market Outlook 2032: Rising Prevalence and Innovative Pipeline Therapies Drive Growth, analyses DelveInsight

Fibrodysplasia Ossificans Progressiva Market The Fibrodysplasia Ossificans Progressiva (FOP) market is projected to witness substantial growth during the forecast period, primarily driven by increasing disease awareness and improving diagnosis rates. In addition, the introduction of multiple pipeline therapies across various … Continue reading →

Lupus Nephritis Market to Surpass USD 1.8 Billion by 2034 | 20+ Companies and Emerging Therapies Driving Growth, analyses DelveInsight

Lupus Nephritis Market Prominent Lupus Nephritis companies working in the market are Aurinia Pharmaceuticals, Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, Otsuka Pharmaceutical, MorphoSys, Vertice Pharma, Pharmaceutical Associates Inc., Sun Pharmaceutical, Abbott, Johnson & Johnson Private Limited, Bayer, Sanofi, Sumitomo Corporation, … Continue reading →

Metastatic Triple-Negative Breast Cancer Market: Strong Growth Potential Across APAC Through 2036, Driven by Innovation and Rising Disease Burden | DelveInsight

Metastatic Triple-Negative Breast Cancer Market Leading Metastatic Triple-Negative Breast Cancer companies include AstraZeneca, Takeda, Novartis, Roche, Eli Lilly, Merck, Bristol-Myers Squibb, Gilead Sciences, and others. DelveInsight’s report, “Metastatic Triple Negative Breast Cancer Patient Pool Analysis, Market Size, and Market Forecast … Continue reading →

PARP Inhibitor Clinical Pipeline Demonstrates Strong Momentum with 30+ Companies Advancing Innovative Therapies | DelveInsight

PARP Inhibitor Pipeline Insight Leading PARP Inhibitor companies driving innovation in this space include TESARO, AstraZeneca, Sun BioPharma, Eisai Co., BeiGene, IMPACT Therapeutics, and Ribon Therapeutics, among others. DelveInsight’s “PARP Inhibitor Pipeline Insights 2026” report delivers a comprehensive overview of … Continue reading →